Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Auriculotherapy, specifically the cryo-auriculotherapy protocol developed by Ramsay Générale de Santé, is a non-pharmacological intervention used to manage and prevent chronic pain. The procedure involves the application of liquid nitrogen via a cryospray to specific neurophysiological points on the auricle (ear), such as A4, C18, D9, C9, DIX, H13, G14, and FXVII. This stimulation is intended to modulate the central nervous system's pain processing pathways. In clinical settings, it is being evaluated for its efficacy in reducing the incidence of Chronic Post-Surgical Pain (CPSP) in women undergoing mastectomy with immediate reconstruction. The therapy aims to provide a preventative analgesic effect when added to standard anesthetic protocols.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on auriculotherapy.